The concomitant estrogen-dependent diseases and the ovarian reserve condition for patients with severe peritoneal endometriosis, included in the vitro fertilization programmes
- Authors: Ershova I.Y.1,2, Krasnopolskaya K.V.1,2, Orazov M.R.3, Lagutina E.V.3
-
Affiliations:
- Moscow Regional Research Institute of Obstetrics and Gynecology
- Prior Clinic
- People’s Friendship University of Russia
- Issue: Vol 23, No 5 (2021)
- Pages: 386-391
- Section: ORIGINAL ARTICLE
- URL: https://ogarev-online.ru/2079-5831/article/view/88599
- DOI: https://doi.org/10.26442/20795696.2021.5.201058
- ID: 88599
Cite item
Full Text
Abstract
Aim. Is specification of the nature and frequency of concomitant forms of genital endometriosis and other estrogen-dependent diseases (EDD) for the infertile women with severe peritoneal endometriosis (PE), as well as the assessment of the ovarian reserve condition for the patients of different ages.
Materials and methods. The total 142 infertile women with severe peritoneal endometriosis (III–IV stage of the external genital endometriosis according to the American Fertility Society classification) were examined at the age of 32.3±3.2 years (min–max = 23–40 years). The clinical status assessment was conducted, using a standard set of diagnostic procedures, prescribed for the inclusion of patients in the IVF program. The ovarian reserve was estimated by the level of the anti-Mullerian Hormone level determined by the immunoenzyme method.
Results. The concomitant 2-sided endometriotic ovarian cysts (96%), myoma (19.7%) and the adenomyosis (16.9%) were most common for the patients with severe peritoneal endometriosis. The severely reduced the anti-Mullerian Hormone rates (<0.4 ng/ml) were much higher among patients >35 years old (24.6% compared to 10.6% for younger patients; p=0.028).
Conclusion. The infertility for severe peritoneal endometriosis is supported by concomitant estrogen-dependent diseases, of which 2-sided endometriomas, adenomyosis and uterine myoma are of the most pathological.
The low efficiency of IVF in the treatment of patients with severe peritoneal endometriosis and concomitant estrogen-dependent diseases is explained by the aggravation of the embryonic and endometrial factors for the infertility. The other reason that worsens the results of IVF for such patients is late reproductive age (>35 years) that increases the observed reduction of the ovarian reserve.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Irina Yu. Ershova
Moscow Regional Research Institute of Obstetrics and Gynecology; Prior Clinic
Author for correspondence.
Email: i3236987@gmail.com
ORCID iD: 0000-0001-9327-0656
Cand. Sci. (Med.)
Russian Federation, Moscow; MoscowKsenia V. Krasnopolskaya
Moscow Regional Research Institute of Obstetrics and Gynecology; Prior Clinic
Email: deti222@mail.ru
ORCID iD: 0000-0002-1275-9220
D. Sci. (Med.), Prof., Corr. Memb. RAS
Russian Federation, Moscow; MoscowMekan R. Orazov
People’s Friendship University of Russia
Email: omekan@mail.ru
ORCID iD: 0000-0002-5342-8129
D. Sci. (Med.)
Russian Federation, MoscowElena V. Lagutina
People’s Friendship University of Russia
Email: Lagutina_e.v@mail.ru
ORCID iD: 0000-0002-3895-8359
Graduate Student
Russian Federation, MoscowReferences
- Barnett R, Banks N, Decherney AH. Endometriosis and Fertility Preservation. Clin Obstet Gynecol. 2017;60(3):517-23. doi: 10.1097/GRF.0000000000000311
- Carrillo L, Seidman DS, Cittadini E, Meirow D. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet. 2016;33(3):317-23. doi: 10.1007/s10815-016-0646-z
- Llarena NC, Falcone T, Flyckt RL. Fertility preservation in women with endometriosis. Clin Med Insights Reprod Health. 2019;13:1179558119873386. doi: 10.1177/1179558119873386
- Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39(4):535-49. doi: 10.1016/j.ogc.2012.10.002
- Cranney R, Condous G, Reid S. An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma. Acta Obstet Gynecol Scand. 2017;96(6):633-43. doi: 10.1111/aogs.13114
- Bulun SE, Monsivais D, Kakinuma T, et al. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med. 2015;33(3):220-4. doi: 10.1055/s-0035-1554053
- Marquardt RM, Kim TH, Shin JH, Jeong JW. Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? Int J Mol Sci. 2019;20(15):3822. doi: 10.3390/ijms20153822
- Краснопольская К.В., Назаренко Т.А. Клинические аспекты лечения бесплодия в браке. Диагностические и терапевтические программы с использованием методов восстановления естественной фертильности и вспомогательных репродуктивных технологий: руководство. М: ГЭОТАР-Медиа, 2013 [Krasnopolskaia KV, Nazarenko TA. Clinical aspects of the treatment of infertility in marriage. Diagnostic and therapeutic programs using natural fertility restoration and assisted reproductive technologies: a guide. Moscow: GEOTAR-Media, 2013 (in Russian)].
- Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017;217(2):129-40. doi: 10.1016/j.ajog.2017.02.027
- Johnstone EB, Link MH. Controversies in the Management of Endometrioma To Cure Sometimes, to Treat Often, to Comfort Always? Clin Obstet Gynecol. 2015;58(4):754-64. doi: 10.1097/GRF.0000000000000151
- Kodaman PH. Current strategies for endometriosis management. Obstet Gynecol Clin North Am. 2015;42(1):87-101. doi: 10.1016/j.ogc.2014.10.005
- Somigliana E, Vigano P, Benaglia L, et al. Management of Endometriosis in the Infertile Patient. Semin Reprod Med. 2017;35(1):31-7. doi: 10.1055/s-0036-1597125
- Benaglia L, Castiglioni M, Paffoni A, et al. Is endometrioma-associated damage to ovarian reserve progressive? Insights from IVF cycles. Hum Reprod Update. 2015;21(4):486-99. doi: 10.1093/humupd/dmv012
- Kasapoglu I, Ata B, Uyaniklar O, et al. Endometrioma-related reduction of ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril. 2018;110(1):122-7. doi: 10.1016/j.fertnstert.2018.03.015
- Younis JS, Shapso N, Fleming R, et al. Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(3):375-91. doi: 10.1093/humupd/dmy049
- Ferrero S, Scala C, Tafi E, et al. Impact of large ovarian endometriomas on the response to superovulation for in vitro fertilization: a retrospective study. Eur J Obstet Gynecol Reprod Biol. 2017;213:17-21. doi: 10.1016/j.ejogrb.2017.04.003
- Kitajima M, Khan KN, Harada A, et al. Association between ovarian endometrioma and ovarian reserve. Front Biosci (Elite Ed). 2018;10:92-102. doi: 10.2741/e810
- Maggiore LRU, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol. 2017;209:81-5. doi: 10.1016/j.ejogrb.2016.02.035
- Park HJ, Kim H, Lee GH, et al. Could surgical management improve the IVF outcomes in infertile women with endometriomas. A review. Obstet Gynecol Sci. 2019;62(1):1-10. doi: 10.5468/ogs.2019.62.1.1
- Vignali M, Mabrouk M, Ciocca E, et al. Surgical excision of ovarian endometriomas: Does it truly impair ovarian reserve? Long term anti-Müllerian hormone (AMH) changes after surgery. J Obstet Gynaecol Res. 2015;41(11):1773-8. doi: 10.1111/jog.12830
- Goodman LR, Golberg JM, Flyckt RL, et al. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016;215(5):589.e1-589.e6. doi: 10.1016/j.ajog.2016.05.029
- Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand. 2017;96(6):715-26. doi: 10.1111/aogs.13158
- Vercellini P, Bonfanti I, Berlanda N. Adenomyosis and infertility: is there a causal link? Expert Rev Endocrinol Metab. 2019;14(6):365-7. doi: 10.1080/17446651.2019.1697675
- Vlahos NF, Theodoridis TD, Partsinevelos GA. Myomas and Adenomyosis: Impact on Reproductive Outcome. Biomed Res Int. 2017;2017:5926470. doi: 10.1155/2017/5926470
- Zepiridis LI, Grimbizis GF, Tarlatzis BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:66-73. doi: 10.1016/j.bpobgyn.2015.12.001
- Rothenberger NJ, Somasundaram A, Stabile LP. The Role of the Estrogen Pathway in the Tumor Microenvironment. Int J Mol Sci. 2018;19(2):611. doi: 10.3390/ijms19020611
- Liang J, Shang Y. Estrogen and cancer. Annu Rev Physiol. 2013;75:225-40. doi: 10.1146/annurev-physiol-030212-183708
Supplementary files
